Search the collection

Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 1
ArticlesPeer ReviewedFull Text
Pharmacological Inhibition of Chitotriosidase (CHIT1) as a Novel Therapeutic Approach for Sarcoidosis Pharmacological Inhibition of Chitotriosidase (CHIT1) as a Novel Therapeutic Approach for Sarcoido...
Author / Creator:Dymek B ; Sklepkiewicz P ; Mlacki M ; Güner NC ; Nejman-Gryz P ; Drzewicka K ; Przysucha N ; Rymaszewska A ; Paplinska-Goryca M ; Zagozdzon A ; Proboszcz M ; Krzemiński Ł ; von der Thüsen JH ; Górska K ; Dzwonek K ; Zasłona Z ; Dobrzanski P ; Krenke R
Publisher:Dove Medical Press
Journal title:Journal of inflammation research, 2022-09, Vol.15, p.5621-5634
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 2
ArticlesPeer ReviewedFull Text
Pharmacological Inhibition of Chitotriosidase (CHIT1) as a Novel Therapeutic Approach for Sarcoidosis
Author / Creator:Dymek, Barbara ; Sklepkiewicz, Piotr ; Mlacki, Michal ; Güner, Nazan Cemre ; Nejman-Gryz, Patrycja ; Drzewicka, Katarzyna ; Przysucha, Natalia ; Rymaszewska, Aleksandra ; Paplinska-Goryca, Magdalena ; Zagozdzon, Agnieszka ; Proboszcz, Małgorzata ; Krzemiński, Łukasz ; von der Thüsen, Jan H ; Górska, Katarzyna ; Dzwonek, Karolina ; Zasłona, Zbigniew ; Dobrzanski, Pawel ; Krenke, Rafał
Publisher:Macclesfield: Dove Medical Press Limited
Journal title:Journal of inflammation research, 2022-01, Vol.15, p.5621-5634
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 3
Newsletter articlesFull Text
Molecure to regain worldwide rights to dual chitinase inhibitor OATD-01
Publisher:NewsRX LLC
Journal title:World Disease Weekly, 2022, p.59
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 4
Newsletter articlesFull Text
Molecure to regain worldwide rights to dual chitinase inhibitor OATD-01
Publisher:New York: PR Newswire Association LLC
Journal title:PR Newswire, 2022
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 5
Newsletter articlesFull Text
Molecure to regain worldwide rights to dual chitinase inhibitor OATD-01
Publisher:New York: PR Newswire Association LLC
Journal title:PR Newswire Europe Including UK Disclose, 2022
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 6
Newsletter articlesFull Text
Mechanism of catalytic apparatus of human chitotriosidase-1 and its dual inactivation mode by the first-in-class OATD-01 inhibitor
Publisher:NewsRX LLC
Journal title:Life Science Weekly, 2025, p.2599
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 7
Newsletter articlesFull Text
Clinical Trial: Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis
Publisher:Washington, D.C: HT Digital Streams Limited
Journal title:US Fed News Service, Including US State News, 2024
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 8
Newsletter articlesFull Text
First patient in the UK is dosed in the OATD-01 Phase 2 KITE study in pulmonary sarcoidosis
Publisher:New York: NASDAQ OMX Corporate Solutions, Inc
Journal title:NASDAQ OMX's News Release Distribution Channel, 2024
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 9
Newsletter articlesFull Text
Press Release: First patient in the UK is dosed in the OATD-01 Phase 2 KITE study in pulmonary sarcoidosis
Publisher:New York: Dow Jones & Company Inc
Journal title:Dow Jones Institutional News, 2024
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 10
Newsletter articlesFull Text
Press Release: First patient in the UK is dosed in the OATD-01 Phase 2 KITE study in pulmonary sarcoidosis
Publisher:New York: Dow Jones & Company Inc
Journal title:Dow Jones Institutional News, 2024
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 11
Newsletter articlesFull Text
Molecure receives approval to initiate a Phase II clinical trial (KITE) for OATD-01 for the treatment of pulmonary sarcoidosis in selected countries of the European Union and Norway
Publisher:New York: NASDAQ OMX Corporate Solutions, Inc
Journal title:NASDAQ OMX's News Release Distribution Channel, 2024
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 12
ArticlesFull Text
Findings from OncoArendi Therapeutics SA Update Understanding of Idiopathic Pulmonary Fibrosis (Discovery of OATD-01, a First-in-Class Chitinase Inhibitor as Potential New Therapeutics for Idiopathic...
Publisher:NewsRX LLC
Journal title:Obesity, fitness, & wellness week, 2020-11, p.733
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 13
Newsletter articlesFull Text
Press Release: The U.S. Food and Drug Administration Gives the Green Light to Molecure's Flagship Program -- Phase II Clinical Testing of OATD-01 is Ready for Launch
Publisher:New York: Dow Jones & Company Inc
Journal title:Dow Jones Institutional News, 2023
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 14
Newsletter articlesFull Text
The U.S. Food and Drug Administration Gives the Green Light to Molecure’s Flagship Program – Phase II Clinical Testing of OATD-01 is Ready for Launch
Publisher:New York: NASDAQ OMX Corporate Solutions, Inc
Journal title:NASDAQ OMX's News Release Distribution Channel, 2023
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 15
Newsletter articlesFull Text
Press Release: The U.S. Food and Drug Administration Gives the Green Light to Molecure's Flagship Program -- Phase II Clinical Testing of OATD-01 is Ready for Launch
Publisher:New York: Dow Jones & Company Inc
Journal title:Dow Jones Institutional News, 2023
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 16
Newsletter articlesFull Text
Molecure Files an Investigational New Drug (IND) application for lead clinical candidate OATD-01 with U.S. FDA ahead of a planned Phase 2 pulmonary sarcoidosis study
Publisher:New York: NASDAQ OMX Corporate Solutions, Inc
Journal title:NASDAQ OMX's News Release Distribution Channel, 2023
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 17
Newsletter articlesFull Text
Press Release: Molecure Files an Investigational New Drug (IND) application for lead clinical candidate OATD-01 with U.S. FDA ahead of a planned Phase 2 pulmonary sarcoidosis study
Publisher:New York: Dow Jones & Company Inc
Journal title:Dow Jones Institutional News, 2023
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 18
Newsletter articlesFull Text
Press Release: Molecure Files an Investigational New Drug (IND) application for lead clinical candidate OATD-01 with U.S. FDA ahead of a planned Phase 2 pulmonary sarcoidosis study
Publisher:New York: Dow Jones & Company Inc
Journal title:Dow Jones Institutional News, 2023
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 19
Newsletter articlesFull Text
Press Release: Molecure receives approval to initiate a Phase II clinical trial (KITE) for OATD-01 for the treatment of pulmonary sarcoidosis in selected countries of the European Union and Norway
Publisher:New York: Dow Jones & Company Inc
Journal title:Dow Jones Institutional News, 2024
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 20
Newsletter articlesFull Text
Press Release: Molecure receives approval to initiate a Phase II clinical trial (KITE) for OATD-01 for the treatment of pulmonary sarcoidosis in selected countries of the European Union and Norway
Publisher:New York: Dow Jones & Company Inc
Journal title:Dow Jones Institutional News, 2024
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.

Showing 1 to 20 of 30 results

Export record to excel

Export this record

Export record to excel

Pharmacological Inhibition of Chitotriosidase (CHIT1) as a Novel Therapeutic Approach for Sarcoidosis Pharmacological Inhibition of Chitotriosidase (CHIT1) as a Novel Therapeutic Approach for Sarcoido...

Export this record

Export record to excel

Pharmacological Inhibition of Chitotriosidase (CHIT1) as a Novel Therapeutic Approach for Sarcoidosis

Export this record

Export record to excel

Molecure to regain worldwide rights to dual chitinase inhibitor OATD-01

Export this record

Export record to excel

Molecure to regain worldwide rights to dual chitinase inhibitor OATD-01

Export this record

Export record to excel

Molecure to regain worldwide rights to dual chitinase inhibitor OATD-01

Export this record

Export record to excel

Mechanism of catalytic apparatus of human chitotriosidase-1 and its dual inactivation mode by the first-in-class OATD-01 inhibitor

Export this record

Export record to excel

Clinical Trial: Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis

Export this record

Export record to excel

First patient in the UK is dosed in the OATD-01 Phase 2 KITE study in pulmonary sarcoidosis

Export this record

Export record to excel

Press Release: First patient in the UK is dosed in the OATD-01 Phase 2 KITE study in pulmonary sarcoidosis

Export this record

Export record to excel

Press Release: First patient in the UK is dosed in the OATD-01 Phase 2 KITE study in pulmonary sarcoidosis

Export this record

Export record to excel

Molecure receives approval to initiate a Phase II clinical trial (KITE) for OATD-01 for the treatment of pulmonary sarcoidosis in selected countries of the European Union and Norway

Export this record

Export record to excel

Findings from OncoArendi Therapeutics SA Update Understanding of Idiopathic Pulmonary Fibrosis (Discovery of OATD-01, a First-in-Class Chitinase Inhibitor as Potential New Therapeutics for Idiopathic...

Export this record

Export record to excel

Press Release: The U.S. Food and Drug Administration Gives the Green Light to Molecure's Flagship Program -- Phase II Clinical Testing of OATD-01 is Ready for Launch

Export this record

Export record to excel

The U.S. Food and Drug Administration Gives the Green Light to Molecure’s Flagship Program – Phase II Clinical Testing of OATD-01 is Ready for Launch

Export this record

Export record to excel

Press Release: The U.S. Food and Drug Administration Gives the Green Light to Molecure's Flagship Program -- Phase II Clinical Testing of OATD-01 is Ready for Launch

Export this record

Export record to excel

Molecure Files an Investigational New Drug (IND) application for lead clinical candidate OATD-01 with U.S. FDA ahead of a planned Phase 2 pulmonary sarcoidosis study

Export this record

Export record to excel

Press Release: Molecure Files an Investigational New Drug (IND) application for lead clinical candidate OATD-01 with U.S. FDA ahead of a planned Phase 2 pulmonary sarcoidosis study

Export this record

Export record to excel

Press Release: Molecure Files an Investigational New Drug (IND) application for lead clinical candidate OATD-01 with U.S. FDA ahead of a planned Phase 2 pulmonary sarcoidosis study

Export this record

Export record to excel

Press Release: Molecure receives approval to initiate a Phase II clinical trial (KITE) for OATD-01 for the treatment of pulmonary sarcoidosis in selected countries of the European Union and Norway

Export this record

Export record to excel

Press Release: Molecure receives approval to initiate a Phase II clinical trial (KITE) for OATD-01 for the treatment of pulmonary sarcoidosis in selected countries of the European Union and Norway

Refine your search